Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

IXJ vs. JDOC: which is better?

Bottom line

IXJ vs JDOC: the short answer

IXJ (iShares Global Healthcare ETF) and JDOC (JPMorgan Healthcare Leaders ETF) share a meaningful slice of their top holdings — about 68% by weight.

But IXJ is far broader, holding 124 positions to 61 for JDOC, so beyond the top names it adds exposure JDOC doesn't have.

IXJ is cheaper at 0.38% vs 0.65% — a difference of $27 a year per $10,000 invested.

Over one year, JDOC returned +14.9% vs +14.9% for IXJ.

Updated Nov 19, 2026

IXJ vs JDOC side by side

IXJJDOC
TypeETFETF
Fund familyiSharesJ.P. Morgan
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.38%0.65%
Annual cost per $10k$38$65
10-yr cost on $10k (prospectus)$480$810
Max front loadNoneNone
12b-1 fee0%—
1-yr return+14.9%+14.9%
5-yr return (annualized)+6.4%—
10-yr return (annualized)+8.2%—
Best quarter+13.6%+11.3%
Worst quarter−11.8%−11.9%
Net assets (fund)$3.8B$9.1M
Number of holdings12461
Portfolio turnover2%92%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearIXJJDOCDifference
2025+14.9%+14.9%−0.1%
2024+0.6%−0.6%+1.2%

Source: Fund prospectus bar charts

Holdings overlap

17 of IXJ's top 25 holdings also appear in JDOC's top 25.

Shared top holdings
HoldingIXJJDOC
Eli Lilly And Company10.93%7.76%
Johnson & Johnson7.04%4.82%
Abbvie Inc.5.12%7.85%
Unitedhealth Group Incorporated4.40%5.85%
Merck & Co., Inc.4.12%4.82%
Astrazeneca Plc3.76%3.76%
Roche Holding AG3.75%2.82%
Novartis AG3.71%1.60%
Thermo Fisher Scientific Incorporated2.42%3.73%
Abbott Laboratories2.05%3.11%
Novo Nordisk A/s1.99%2.61%
Intuitive Surgical, Inc.1.83%1.93%
Cvs Health Corporation1.71%2.83%
Danaher Corporation1.56%2.16%
Bristol-myers Squibb Company1.53%3.57%

Source: SEC Form N-PORT

IXJ top 10

  1. Eli Lilly And Company — 10.93%
  2. Johnson & Johnson — 7.04%
  3. Abbvie Inc. — 5.12%
  4. Unitedhealth Group Incorporated — 4.40%
  5. Merck & Co., Inc. — 4.12%
  6. Astrazeneca Plc — 3.76%
  7. Roche Holding AG — 3.75%
  8. Novartis AG — 3.71%
  9. Amgen Inc. — 2.54%
  10. Thermo Fisher Scientific Incorporated — 2.42%

JDOC top 10

  1. AbbVie, Inc. — 7.85%
  2. Eli Lilly & Co. — 7.76%
  3. UnitedHealth Group, Inc. — 5.85%
  4. Merck & Co., Inc. — 4.82%
  5. Johnson & Johnson — 4.82%
  6. AstraZeneca plc — 3.76%
  7. Thermo Fisher Scientific, Inc. — 3.73%
  8. Bristol-Myers Squibb Co. — 3.57%
  9. Abbott Laboratories — 3.11%
  10. CVS Health Corp. — 2.83%

FAQ

What is the difference between IXJ and JDOC?
IXJ (iShares Global Healthcare ETF) and JDOC (JPMorgan Healthcare Leaders ETF) share a meaningful slice of their top holdings — about 68% by weight. But IXJ is far broader, holding 124 positions to 61 for JDOC, so beyond the top names it adds exposure JDOC doesn't have.
Which is cheaper, IXJ or JDOC?
IXJ has the lower expense ratio (0.38%).
Should I own both IXJ and JDOC?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.